(PDF/344.79 KB) (PDF/327.41 KB) It is given as a single 1 ml injection into the muscle around the shoulder (the deltoid) or a muscle of the thigh. This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. (PDF/89.93 KB) (PDF/263.6 KB) (PDF/269.75 KB) (PDF/65.8 KB) (PDF/127.31 KB)
(PDF/161.86 KB) The company anticipates full-year 2020 revenue range to be between $47.2 billion and $48.7 billion, including a negative […]COVID-19 continues to be an extraordinary challenge to the global community.
(PDF/171.75 KB)
(PDF/291.64 KB)
(PDF/89.93 KB) (PDF/62.32 KB)
(PDF/91.48 KB) As a company dedicated to saving and improving lives for more than 100 years, we have a special responsibility to help in the fight against COVID-19.
Every year, the Agency will review any new information that becomes available and this overview will be updated as necessary.Since Ervebo has been given conditional authorisation, the company that markets Ervebo will provide additional details on certain aspects of the production process.Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ervebo have been included in the As for all medicines, data on the use of Ervebo are continuously monitored. (PDF/309.37 KB) (PDF/61.8 KB) (PDF/150.05 KB) (PDF/270.68 KB) Merck has been fully committed to developing an effective response to the COVID-19 pandemic since it was first […]The site sits at the center of an important biotechnology hub Decades before it became a hive of biotechnology activity, South San Francisco was a hotspot for manufacturing technologies.
(PDF/59.63 KB) (PDF/327.41 KB) (PDF/67.99 KB)
(PDF/302.22 KB)
(PDF/325.68 KB) (PDF/95.82 KB) Later, when the person comes into contact with the actual virus, the immune system recognises the virus protein and is already prepared to attack the virus and so protects the person from Ebola virus disease.
(PDF/293.35 KB) Side effects reported with Ervebo are carefully evaluated and any necessary action taken to protect patients.This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. ERVEBO is a suspension for injection supplied as a 1 mL dose in single-dose vials. (PDF/99.3 KB) (PDF/160.46 KB) For the full list of side effects and restrictions of Ervebo, see the Ervebo is effective in protecting adults from Ebola virus disease; however, the duration of this protection is currently unknown. (PDF/327.63 KB) (PDF/145.15 KB) (PDF/152.35 KB)